Valganciclovir Reduces CD8+ T Cell Activation among HIV-infected Patients with Suboptimal CD4+ T cell Recovery During Antiretroviral Therapy
Reported by Jules Levin
CROI 2010 SF
Peter Hunt1, Jeffrey Martin1, Elizabeth Sinclair1, Lorrie Epling1, Juli Teague1, Mark Jacobson1, Russell Tracy2, Lawrence Corey3, and Steven Deeks1
1University of California, San Francisco; 2University of Vermont; 3University of Washington
